Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 572 results for "clopidogrel"

Human medicines European public assessment report (EPAR): Is...

This is a summary of the European public assessment report (EPAR) for Iscover. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and ... European Medicines Agency, 5 days ago

24 images for clopidogrel

TCTMD.com, 2 months ago
MDLinx, 3 months ago
MDLinx, 3 months ago
MDLinx, 4 months ago
MDLinx, 4 months ago
MDLinx, 4 months ago
MDLinx, 4 months ago
MDLinx, 4 months ago
MDLinx, 4 months ago
MDLinx, 4 months ago

Duration of Dual Antiplatelet Therapy after Drug-Eluting Stents

The authors reply: We appreciate the interest in our study. In reply to Sipahi: in the clopidogrel-treated subgroup (6500 patients), the number of new cancers reported was 73 in the group that continued to receive thienopyridine and 55 in the ...
 New England Journal of Medicine3 weeks ago Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation The ISAR-TRIPLE Trial  Journal of the American College of Cardiology5 days ago Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials  British Medical Journal1 week ago Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment After  European Heart Journal1 month ago
[x]  
Tech Times

Clopidogrel With PPIs: No Increased Risk of Stroke

Reuters Health Information By David Douglas February20,2015 NEW YORK (Reuters Health) - Users of clopidogrel and concomitant proton pump inhibitors (PPIs) are not at increased risk of ischemic stroke, according to researchers. "To exert its ...
 Diabetes Care2 months ago Aspirin resistance tied to more severe strokes  UnitedHealthcare1 month ago Resistance To Aspirin May Point To Increased Risks Of Severe Stroke  Tech Times1 month ago Study, Aspirin Resistance Is a Precursor to Stroke  NewsHub South Africa1 month ago
[x]  

McCormack Pharma's Discovery Could Mean New Guidelines For Anti-Platelet Drug Use

Clopidogrel (Plavix) is an anti-platelet drug that is used to prevent the formation of a thrombus (clot) in vulnerable patients. However, a significant proportion of patients who receive clopidogrel remain at risk for subsequent death, myocardial ...
 PharmaceuticalProcessing2 days ago McCormack Pharma's Landmark Discovery could mean New Guidelines for use of Anti-Platelet Drug  TickerTech.com3 days ago McCormack Pharma 's Landmark Discovery Could Mean New Guidelines For Use Of Anti-Platelet Drug  BioSpace1 day ago
[x]  

Clopidogrel Bisulfate Market 2015-2020 Research Reviews

 Securities Technology Monitor4 days ago
[x]  

Post-Hoc Analyses of TRA-2°P Trial Show Efficacy of Zontivity with Aspirin and Clopidogrel

— Merck announced results from two post-hoc analyses of the TRA 2°P TIMI 50 (Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) trial of Zontivity (vorapaxar), one of the largest secondary prevention studies ...
 Diagnostic & Invasive Cardiology1 month ago Two New Post-Hoc Analyses of TRA 2°P TIMI 50 Study Showed ZONTIVITY® (vorapaxar) Added to Aspirin and/or Clopidogrel Reduced Acute Limb Ischemia and Peripheral Revascularizations, Respectively, in Certain Patients with Peripheral Arterial Disease  TMC Net1 month ago Merck : Two New Post-Hoc Analyses of TRA 2°P TIMI 50 Study Showed ZONTIVITY® (vorapaxar) Added to Aspirin and/or Clopidogrel Reduced Acute Limb Ischemia and Peripheral Revascularizations, Respectively, in Certain Patients with Peripheral Arterial Disease  4 Traders1 month ago Vorapaxar may reduce acute limb ischemia, peripheral revascularization in patients with PAD  Orthopedics Today1 month ago
[x]  

DIFFERENTIAL IMPACT OF HIGH PLATELET REACTIVITY ON CLOPIDOGREL IN WOMEN AND MEN FOLLOWING PERCUTANEOUS CORONARY INTERVENTION (PCI) WITH DES

Note: Since your browser does not support Javascript, you must press the Continue button once
 Journal of the American College of Cardiology1 month ago Stroke following percutaneous coronary intervention: type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007-12  European Heart Journal5 days ago HIGH PLATELET REACTIVITY IS ASSOCIATED WITH VASCULAR FUNCTION IN PATIENTS AFTER PERCUTANEOUS CORONARY INTERVENTION RECEIVING CLOPIDOGREL  Journal of the American College of Cardiology1 month ago ASSOCIATION OF GENOTYPING WITH PLATELET ACTIVATION AND CARDIOVASCULAR OUTCOME IN PATIENTS AFTER PERCUTANEOUS CORONARY INTERVENTION RECEIVING CLOPIDOGREL: TWO PIECES OF THE PUZZLE OF CLOPIDOGREL RESISTANCE  Journal of the American College of Cardiology1 month ago

Reply Has Prasugrel Been Compared Correctly With Clopidogrel in NonST-Segment Elevation Acute Coronary Syndrome?

We thank Dr. Lozano and colleagues for their interest in our paper. However, they misinterpret the results of the ACCOAST (Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction) and of the preceding trials.
 Journal of the American College of Cardiology5 days ago Has Prasugrel Been Compared Correctly With Clopidogrel in NonST-Segment Elevation Acute Coronary Syndrome?  Journal of the American College of Cardiology5 days ago

Elevated Serum Fibrinogen An Independent Link Between Diabetes Mellitus, Impaired On-Clopidogrel Platelet Inhibition, and Major Adverse Cardiac Events After Percutaneous Coronary Intervention

We read with great interest the recent paper and editorial written by Angiolillo etal. (1) and Price (2) in the Journal regarding diminished platelet inhibition (PI) response to clopidogrel in diabetic patients attributable to impaired metabolism of ...
 Journal of the American College of Cardiology5 days ago Reply Elevated Serum Fibrinogen: An Independent Link Between Diabetes Mellitus, Impaired On-Clopidogrel Platelet Inhibition, and Major Adverse Cardiac Events After Percutaneous Coronary Intervention  Journal of the American College of Cardiology5 days ago

The Medicines Co.'s Kengreal Briefing Documents Positive - Analyst Blog

The FDA further noted that while the benefit of Kengreal compared to Bristol-Myers BMY and Sanofi's SNY Plavix (clopidogrel) is small, the risk is smaller. We remind investors that The Medicines Co. had received a complete response letter from the ...
 Nasdaq1 week ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - clopidogrel
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less